CompletedPHASE1, PHASE2NCT00122473
Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
Studying Dermatofibrosarcoma protuberans
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Dermatologic Cooperative Oncology Group
- Principal Investigator
- Selma Ugurel, MDSkin Cancer Unit, German Cancer Research Center Heidelberg and Department of Dermatology, University Hospital of Mannheim, Mannheim, Germany
- Intervention
- Imatinib (Glivec)(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2007
Study locations (4)
- Skin Cancer Unit, German Cancer Research Center and Department of Dermatology, University Hospital of Mannheim, Mannheim, Baden-Wurttemberg, Germany
- Department of Dermatology, ElbeKliniken - Klinikum Buxtehude, Buxtehude, Lower Saxony, Germany
- Department of Dermatology, The Saarland University Hospital, Homburg/Saar, Saarland, Germany
- Department of Dermatology, Martin-Luther-University Halle-Wittenberg, Halle, Saxony-Anhalt, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00122473 on ClinicalTrials.gov